Day: June 25, 2024

Company Announcement, Helsinki, 25 June 2024 at 9:30 AM (EEST) Insider Information: Nexstim Plc’s offering for an EUR 750,000 convertible bond has closed and EUR 650,000 of the bond was subscribed for NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Nexstim Plc (NXTMH:HEX) announces that its offering for an EUR 750,000 convertible bond has been closed. The convertible bond has been subscribed for a total amount of EUR 650,000 by the following parties: Leena Niemistö through Kaikarhenni Oy, Ossi Haapaniemi through Kalksten Finance Oy, Kyösti Kakkonen through Joensuun Kauppa ja Kone Oy, and Tero Weckroth through WRCC Invest Oy. The...

Syensqo launches Share Buyback Program  Brussels, Belgium – June 25, 2024 – 08:30 CEST In accordance with article 7:215 of the Belgian Code of Companies and Associations, Syensqo SA (“Syensqo” or the “Company”) announces the launch of a share buyback program, effective as of 25 June 2024 (the “Share Buyback Program”).  The repurchase of Syensqo shares under the Share Buyback Program intends to cover current and future obligations under Syensqo’s current Long Term Incentive Plans for its employees.  Under this program, Syensqo may acquire a maximum of 983,000 Syensqo shares. The Share Buyback Program commences on 25 June 2024 and will run until 20 December 2024 at the latest. The Share Buyback Program may be suspended or discontinued at any time and any shares acquired under the Share Buyback Program will be held as treasury...

OCREVUS subcutaneous (SC) injection offers a new, 10-minute administration of OCREVUS with comparable efficacy and safety to intravenous infusion (IV) OCREVUS SC provides an additional treatment option without the need for IV facilities, expanding accessibility for patients Roche is working closely with national health systems in Europe to ensure people with multiple sclerosis can access OCREVUS SC as quickly as possibleBasel, 25 June 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted marketing authorisation for OCREVUS® (ocrelizumab) subcutaneous (SC) for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). OCREVUS SC is a 10-minute injection that maintains the same twice-yearly schedule as the previously approved intravenous (IV)...

  The Hague, June 25, 2024 – Aegon today presents its plans to accelerate the transformation of Aegon UK into a leading digital savings and retirement platform. The plans will be outlined at a webinar hosted from London by Lard Friese, CEO of Aegon, and Mike Holliday-Williams, CEO of Aegon UK, together with other senior leaders of Aegon UK. Aegon CEO, Lard Friese, commented: “Aegon’s ambition is to create leading businesses in investment, protection, and retirement solutions. Aegon UK is well positioned to capture the opportunities of the UK’s large and growing market for long-term savings and retirement solutions. I have great confidence in our UK colleagues to deliver on our plans to transform Aegon UK into a champion business.” Aegon UK operates an interconnected business model with three growth franchises: the Workplace platform,...

HONG KONG, June 25, 2024 (GLOBE NEWSWIRE) — QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading online learning service provider in China, today opened its office in Hong Kong. Timed with the opening, the company launched co-branded research on China’s Silver Economy, entitled “White Paper on Unveiling Golden Opportunities in China’s Silver Economy, 2023” (“White Paper”). The inaugural Hong Kong office is the company’s first office outside Mainland China. Located strategically in the Exchange Square, a prime area near investors and business leaders, this new hub represents a significant milestone in QuantaSing’s market expansion and global outreach. From this Hong Kong base, QuantaSing is actively seeking new business opportunities with a global perspective, broadening its reach beyond its original...

Toronto, June 24, 2024 (GLOBE NEWSWIRE) — Faircourt Asset Management Inc., as Manager of the Faircourt Fund (NEO:FGX), is pleased to announce the monthly distribution payable on the Shares of the below listed Fund.Faircourt Funds Trading Symbol Distribution Amount (per share/unit) Ex-Dividend Date Record Date Payable DateFaircourt Gold Income Corp. FGX $0.024 June 24, 2024 June 28, 2024 July 15, 2024Faircourt Asset Management Inc. is the Investment Advisor for Faircourt Gold Income Corp. This press release is not for distribution in the United States or over United States wire services. For further information on the Faircourt Funds, please visit www.faircourtassetmgt.com or please contact 1-800-831-0304. You will usually pay brokerage fees to your dealer if you purchase or sell Shares of the Fund on the NEO Exchange...